Healthcare Global Enterprises Li (NSE: HCG) and Jupiter Life Line Hospitals Ltd (NSE: JLHL) are both listed in the Hospitals and Healthcare Centers industry. Healthcare Global Enterprises Li has a market capitalisation of ₹8,761 Cr and Jupiter Life Line Hospitals ₹8,642 Cr, as of 9 Nov 2026. Their P/E ratios are 611.3 and 44.5 respectively. Return on equity is 1.90% for Healthcare Global Enterprises Li and 13.73% for Jupiter Life Line Hospitals. Over one year, Healthcare Global Enterprises Li's share price is down 22.0% and Jupiter Life Line Hospitals's is down 6.6%.
| Metric | Healthcare Global Enterprises Li | Jupiter Life Line Hospitals |
|---|---|---|
| NSE Symbol | HCG | JLHL |
| BSE Code | 539787 | 543980 |
| Share Price | ₹587.10 | ₹293.00 |
| Market Cap | ₹8,761 Cr | ₹8,642 Cr |
| P/E Ratio | 611.3 | 44.5 |
| Return on Equity | 1.90% | 13.73% |
| Return on Assets | 3.81% | 7.44% |
| Dividend Yield | — | 0.08% |
| Beta (1Y) | 0.35 | 0.1 |
| 1-Year Price Change | -22.0% | -6.6% |
| 3-Month Price Change | -18.0% | -8.4% |
| 52-Week Range | ₹513.30 – ₹775.00 | ₹233.40 – ₹340.00 |
| Latest Quarter | Q2 FY27 | Q2 FY27 |
| Quarterly Revenue | ₹732 Cr | ₹457 Cr |
| Quarterly Net Profit | ₹9 Cr | ₹56 Cr |
| Net Margin | 1.3% | 12.3% |
| EPS (Basic, Quarter) | ₹0.32 | ₹1.72 |
| Results Basis | consolidated | consolidated |
| Headquarters | Bengaluru, Karnataka | Mumbai, Maharashtra |
The figures sit side by side and are not ranked. Quarterly figures are in ₹ crore, parsed from each company's exchange filing (XBRL); the two companies' latest quarters can differ.
HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. The company offers cancer diagnostics services, including genomics and molecular diagnostics, digital PET, preventive oncology, physical examination, laboratory tests, home health services, digital pathology, and CTC detection; treatment services, such as medical oncology and haemato-oncology, radiation and surgical oncology, molecular imaging and theranostics, chemotherapy, robotic surgery, actinium and lutetium therapy, immunotherapy, psycho-oncology, targeted drug therapy, bone marro…
Jupiter Life Line Hospitals Limited, a multi-specialty hospital, provides health care services under the Jupiter brand in India. The company offers treatments in the areas of bariatric surgery, breast care center, cardiac surgery, cardiology, chest medicine, dental care, dermatology, endocrinology and diabetes, ENT, gastroenterology, general surgery and minimal access surgery, hematology and BMT, HPB and surgical gastroenterology, infectious diseases, internal medicine, interventional radiology, mental health, nephrology, neurology, neurosurgery, nutrition and dietetics, Obs and gynecology, on…
Healthcare Global Enterprises Li has a market capitalisation of ₹8,761 Cr, against ₹8,642 Cr for Jupiter Life Line Hospitals as of 9 Nov 2026, so the two are about the same size by market cap.
Healthcare Global Enterprises Li has a P/E of 611.3 and Jupiter Life Line Hospitals a P/E of 44.5 as of 9 Nov 2026.
Healthcare Global Enterprises Li has a return on equity of 1.90% and Jupiter Life Line Hospitals 13.73%.
Healthcare Global Enterprises Li's share price is down 22.0% over one year and Jupiter Life Line Hospitals's is down 6.6%.
Healthcare Global Enterprises Li reported revenue of ₹732 Cr and net profit of ₹9 Cr for Q2 FY27. Jupiter Life Line Hospitals reported revenue of ₹457 Cr and net profit of ₹56 Cr for Q2 FY27. Figures are parsed from each company's exchange filing.
Both are classified under Health Care Providers and Services > Health Care Facilities > Hospitals and Healthcare Centers on FinBizNet.
No. The page lays the two companies' published figures side by side and draws no conclusion from them. It is descriptive market data, not investment advice.
Data as of 9 Nov 2026. Descriptive market data only — not investment advice.